AVLN Insider Trading Activity and SEC Form 4 Filings
AVLN insider trading summary
Over the past 12 months, insiders at Avalyn Pharma Inc. (AVLN) reported 1 open-market purchase worth $10.0M by 1 insider and no sales on SEC Form 4. Net insider buying was $10.0M.
Latest AVLN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 1, 2026 | Novo Holdings A/S | Insider | Buy | $10.0M (555,555 @ $18.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.